Global Smart Syringes Market Size, Trends & Growth Opportunity, By Product Type (Auto-Disable Syringes, Active Safety Syringes, and Passive Safety Syringes), By Application (Vaccination, Blood Specimen Collection, and Drug Delivery), By End User (Hospitals & HMOs, Family Practices (Physicians), Diabetic Patients, Psychiatrics and Others), By Region and Forecast Till 2027.
Report ID : IR1001610 | Industries : Healthcare | Published On :June 2024 | Page Count : 178
Global Smart Syringes Market Size, Trends & Growth Opportunity, By Product Type (Auto-Disable Syringes, Active Safety Syringes, and Passive Safety Syringes), By Application (Vaccination, Blood Specimen Collection, and Drug Delivery), By End User (Hospitals & HMOs, Family Practices (Physicians), Diabetic Patients, Psychiatrics and Others), By Region and Forecast Till 2027.
Global Smart Syringes Market
The Global Smart Syringes Market was valued at US$7.2 billion in 2021 and it is expected to reach at US$13.22 billion in 2027 at a CAGR of 10.66% during forecast period 2022-2027.
Smart syringes are a type of medical device with safety features to stop syringe reuse and regulate risky injection techniques. These syringes have features that stop the spread of blood-borne diseases such the hepatitis B virus (HBV), hepatitis C virus (HCV), and human immunodeficiency virus as well as needlestick injuries to the user (HIV). They support a variety of applications, including the taking of blood samples, the administration of medications, and vaccination.
Market Drivers
The need for smart syringes, which are used for administering pharmaceuticals and vaccinations, is being driven by the rising prevalence of chronic diseases like diabetes, cancer, and autoimmune disorders. The market for smart syringes is expanding as a result of the development of cutting-edge technologies including auto-disable syringes, prefilled syringes, and needle-free injectors.
Market Restraints
The development of the worldwide smart syringes market is anticipated to be hampered by the high cost of smart syringes, particularly passive safety syringes, as well as a lack of awareness in underdeveloped countries and alternative drug administration systems.
Market Segmentation
The global smart syringes market is segmented into product type such as auto-disable syringes, active safety syringes, and passive safety syringes. By application such as vaccination, blood specimen collection, and drug delivery. Further, market is segmented into end user such as hospitals & HMOs, family practices (physicians), diabetic patients, psychiatrics and, others.
Regional Analysis
The smart syringes market is segmented into five regions such as North America, Latin America, Europe, Asia Pacific, and Middle East & Africa. The region with the largest market share in the global market for smart syringes is predicted to be North America, followed by Europe and Asia-Pacific. The second-largest market, Europe, is anticipated to generate the maximum income over the forecast period. Due to several advancements made in the healthcare sector in nations like Germany, France, and Spain. Due to rising demand for less invasive medical procedures and rising healthcare spending in the area, the APAC is likely to be a developing market for smart syringes and to experience the greatest CAGR throughout the forecasted period.
Key Players
Some key operating players are listed in this report such as Becton, Dickinson and Company, Gerresheimer AG, Baxter, Terumo Corporation, B. Braun Melsungen AG, AdvaCare Pharma, Cardinal Health, Parker Hannifin Corp, Numedico Technologies Pty Ltd, Retractable Technologies, Inc., etc.
Market Taxonomy
By Product Type
• Auto-disable syringes
• Active safety syringes
• Passive safety syringes
By Application
• Vaccination
• Blood Specimen Collection
• Drug delivery
By End User
• Hospitals & HMOs
• Family practices (Physicians)
• Diabetic patients
• Psychiatrics
• Others
By Region
• North America
• Latin America
• Europe
• Asia Pacific
• Middle East & Africa
Global Smart Syringes Market
1 Introduction
1.1 Objective of the Study
1.2 Market definition
1.3 Market Scope
2 Research Methodology
2.1 Data Mining
2.2 Validation
2.3 Primary Interviews
2.4 List of Data Sources
3 Executive Summary
4 Global Smart Syringes Market Outlook
4.1 Overview
4.2 Market Dynamics
4.2.1 Drivers
4.2.2 Restraints
4.2.3 Opportunities
4.3 Porters Five Force Model
4.4 Value Chain Analysis
5 Global Smart Syringes Solution Market, By Product Type
5.1 Y-o-Y Growth Comparison, By Product Type
5.2 Global Smart Syringes Market Share Analysis, By Product Type
5.3 Global Smart Syringes Market Size and Forecast, By Product Type
5.3.1 Auto-Disable Syringes
5.3.2 Active Safety Syringes
5.3.3 Passive Safety Syringes
6 Global Smart Syringes Solution Market, By Application
6.1 Y-o-Y Growth Comparison, By Application
6.2 Global Smart Syringes Market Share Analysis, By Application
6.3 Global Smart Syringes Market Size and Forecast, By Application
6.3.1 Vaccination
6.3.2 Blood Specimen Collection
6.3.3 Drug Delivery
7 Global Smart Syringes Solution Market, By End User
7.1 Y-o-Y Growth Comparison, By End User
7.2 Global Smart Syringes Market Share Analysis, By End User
7.3 Global Smart Syringes Market Size Analysis, By End User
7.3.1 Hospitals & HMOs
7.3.2 Family Practices (Physicians)
7.3.3 Diabetic Patients
7.3.4 Psychiatrics
7.3.5 Others
8 Global Smart Syringes Market, By Region
8.1 Global Smart Syringes Market Share Analysis, By Region
8.2 Global Smart Syringes Market Size Analysis, By Region
9 North America Smart Syringes Analysis and Forecast (2022-2027)
9.1 Introduction
9.2 North America Smart Syringes Market Share Analysis, By Product Type
9.3 North America Smart Syringes Market Size and Forecast, By Application
9.4 North America Smart Syringes Market Size and Forecast, By End User
9.5 North America Smart Syringes Market Size and Forecast, By Country
9.5.1 U.S
9.5.1 Canada
9.5.3 Mexico
10 Europe Smart Syringes Market Analysis and Forecast (2022-2027)
10.1 Introduction
10.2 Europe Smart Syringes Market Share Analysis, By Product Type
10.3 Europe Smart Syringes Market Size and Forecast, By Application
10.4 Europe Smart Syringes Market Size and Forecast, By End User
10.5 Europe Smart Syringes Market Size and Forecast, By Country
10.5.1 Germany
10.5.2 France
10.5.3 UK
10.5.4 Rest of Europe
11 Asia Pacific Smart Syringes Market Analysis and Forecast (2022-2027)
11.1 Introduction
11.2 Asia Pacific Smart Syringes Market Size and Forecast, By Product Type
11.3 Asia Pacific Smart Syringes Market Size and Forecast, By Application
11.4 Asia Pacific Smart Syringes Market Size and Forecast, By End User
11.5 Asia Pacific Smart Syringes Market Size and Forecast, By Country
11.5.1 China
11.5.2 Japan
11.5.3 India
11.5.4 Rest of Asia Pacific
12 Latin America Smart Syringes Market Analysis and Forecast (2022-2027)
12.1 Introduction
12.2 Latin America Smart Syringes Market Size and Forecast, By Product Type
12.3 Latin America Smart Syringes Market Size and Forecast, By Application
12.4 Latin America Smart Syringes Market Size and Forecast, By End User
12.5 Latin America Smart Syringes Market Size and Forecast, Country
12.5.1 Brazil
12.5.2. Rest of Latin America
13 Middle East Smart Syringes Market Analysis and Forecast (2022-2027)
13.1 Introduction
13.2 Middle East Smart Syringes Market Share Analysis, By Product Type
13.3 Middle East Smart Syringes Market Size and Forecast, By Application
13.4 Middle East Smart Syringes Market Size and Forecast, By End User
13.5 Middle East Smart Syringes Market Size and Forecast, By Country
13.5.1. Saudi Arabia
13.5.2. UAE
13.5.3. Egypt
13.5.4. Kuwait
13.5.5. South Africa
14 Competitive Analysis
14.1 Competition Dashboard
14.2 Market share Analysis of Top Vendors
14.3 Key Development Strategies
15 Company Profiles
15.1. Becton, Dickinson and Company
15.1.1 Overview
15.1.2 Offerings
15.1.3 Key Financials
15.1.4 Business Segment & Geographic Overview
15.1.5 Key Market Developments
15.1.6 Key Strategies
15.2. Gerresheimer AG
15.2.1 Overview
15.2.2 Offerings
15.2.3 Key Financials
15.2.4 Business Segment & Geographic Overview
15.2.5 Key Market Developments
15.2.6 Key Strategies
15.3. Baxter
15.3.1 Overview
15.3.2 Offerings
15.3.3 Key Financials
15.3.4 Business Segment & Geographic Overview
15.3.5 Key Market Developments
15.3.6 Key Strategies
15.4. Terumo Corporation
15.4.1 Overview
15.4.2 Offerings
15.4.3 Key Financials
15.4.4 Business Segment & Geographic Overview
15.4.5 Key Market Developments
15.4.6 Key Strategies
15.5. B. Braun Melsungen AG
15.5.1 Overview
15.5.2 Offerings
15.5.3 Key Financials
15.5.4 Business Segment & Geographic Overview
15.5.5 Key Market Developments
15.5.6 Key Strategies
15.6. AdvaCare Pharma
15.6.1 Overview
15.6.2 Offerings
15.6.3 Key Financials
15.6.4 Business Segment & Geographic Overview
15.6.5 Key Market Developments
15.6.6 Key Strategies
15.7. Cardinal Health
15.7.1 Overview
15.7.2 Offerings
15.7.3 Key Financials
15.7.4 Business Segment & Geographic Overview
15.7.5 Key Market Developments
15.7.6 Key Strategies
15.8. Parker Hannifin Corp
15.8.1 Overview
15.8.2 Offerings
15.8.3 Key Financials
15.8.4 Business Segment & Geographic Overview
15.8.5 Key Market Developments
15.8.6 Key Strategies
15.9. Numedico Technologies Pty Ltd
15.9.1 Overview
15.9.2 Offerings
15.9.3 Key Financials
15.9.4 Business Segment & Geographic Overview
15.9.5 Key Market Developments
15.9.6 Key Strategies
15.10. Retractable Technologies, Inc
15.10.1 Overview
15.10.2 Offerings
15.10.3 Key Financials
15.10.4 Business Segment & Geographic Overview
15.10.5 Key Market Developments
15.10.6 Key Strategies